Concord Healthcare Group Co., Ltd. (Concord Healthcare) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming a stable share structure with no equity movements during the month.

• Share Capital Structure – H-shares in issue: 313.87 million, par value RMB 1 each. – Domestic shares in issue: 469.79 million, par value RMB 1 each. – Total issued share capital: 783.66 million shares, unchanged from February.

• Treasury Shares and Corporate Actions The company held zero treasury shares and executed no share repurchases, issuances, conversions, option exercises, or warrant activities in March. All sections on convertibles, share options, warrants, and other share-related arrangements were marked “Not applicable.”

• Public Float Compliance Concord Healthcare confirmed that its H-share public float meets the Main Board’s minimum 25% threshold as at month-end, based on publicly available data.

• Governance Confirmation The filing, signed by Company Secretary Pan Lichen, states that all regulatory and listing rule obligations have been fulfilled for the reporting period.

The report indicates a month of capital stability, with the company maintaining its existing equity base and full compliance with Hong Kong listing requirements.